Related Experiment Video
Updated: May 29, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
Anionic or Mixed-Charge Copolypeptides with Potent Antibiofilm Activities
Yu Liu1, Peng Wang1, Xu Zhang2
1Institute of Functional Nano & Soft Materials (FUNSOM), Collaborative Innovation Center of Suzhou Nano Science and Technology, Soochow University, Suzhou 215123, China.
New copolypeptides effectively prevent and eradicate biofilms from Pseudomonas aeruginosa and Staphylococcus aureus without causing antibiotic resistance. These nonbactericidal materials offer a promising approach for treating bacterial biofilm-associated infections (BBAIs).
Area of Science:
- Biomaterials Science
- Infectious Diseases
- Polymer Chemistry
Background:
- Bacterial biofilm-associated infections (BBAIs) pose significant threats due to antibiotic resistance.
- Current treatments often face challenges with efficacy and resistance development.
- There is a critical need for novel antibiofilm strategies.
Purpose of the Study:
- To synthesize and evaluate anionic or mixed-charge copolypeptides for preventing and eradicating Pseudomonas aeruginosa and Staphylococcus aureus biofilms.
- To investigate the mechanism of action of these novel antibiofilm agents.
- To assess the in vivo efficacy and safety of the lead copolypeptide candidate.
Main Methods:
- Copolypeptides were synthesized using ring-opening polymerization and side-chain modifications.
- In vitro antibiofilm assays were performed to determine inhibition and eradication efficacies.
- Mechanism of action was studied through bacterial surface binding, EPS disruption, and virulence factor interaction assays.
- In vivo efficacy was evaluated in a mouse model of acute Pseudomonas aeruginosa lung infection.
Main Results:
- Anionic or mixed-charge copolypeptides, particularly F27E108 and F15E60K60, demonstrated high inhibition rates for P. aeruginosa biofilm formation (up to 96.6%).
- F27E108 achieved significant eradication of P. aeruginosa (98.8%) and S. aureus (91.6%) biofilms.
- The mechanism involves bacterial surface binding, disruption of extracellular polymeric substances, modulation of motility, and binding to virulence factors.
- F27E108 showed potent in vivo antibacterial effects and reduced inflammation in a mouse lung infection model.
Conclusions:
- Novel anionic or mixed-charge copolypeptides are effective nonbactericidal agents against P. aeruginosa and S. aureus biofilms.
- These copolypeptides offer a promising strategy for combating BBAIs without inducing bacterial resistance.
- The developed antibiofilm materials have potential for therapeutic applications in treating persistent bacterial infections.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Bacterial Protein Synthesis
Biofilms
Antifungal Agents
Anionic Chain-Growth Polymerization: Overview
